Dr Milan Dragovic
The Academic Details listed below present information collected by the University up to the end of 2013 and thus may not represent the full academic record.
Phone: 9347 6442
John, A.P., Gee, T., Alexander, S., Ramankutty, P., Dragovic, M. 2015, 'Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service', AUSTRALASIAN PSYCHIATRY, 22, 6, pp. 546-550. Detail
Starkstein, S.E., Dragovic, M., Brockman, S., Wilson, M., Bruno, V., Merello, M.L. 2015, 'The impact of emotional distress on motor blocks and festination in parkinson’s disease', Journal of Neuropsychiatry and Clinical Neurosciences, 27, 2, pp. 121-126. Detail
Starkstein, S.E., Dragovic, M., Dujardin, K., Marsh, L., Martínez-Martín, P., Pontone, G.M., Richard, I.H., Weintraub, D., Leentjens, A.F.G. 2014, 'Anxiety has specific syndromal profiles in parkinson disease: A data-driven approach', American Journal of Geriatric Psychiatry, 22, 12, pp. 1410-1417. Detail
Stefanis, N.C., Dragovic, M., Power, B.D., Jablensky, A.V., Castle, D.J., Morgan, V.A. 2014, 'The effect of drug use on the age at onset of psychotic disorders in an Australian cohort', Schizophrenia Research, 156, pp. 211-216. Detail
Starkstein, S.E., Davis, W.A., Dragovic, M., Cetrullo, V., Davis, T.M.E., Bruce, D.G. 2014, 'Diagnostic criteria for depression in type 2 diabetes: A data-driven approach', PLOS ONE, 9, 11, pp. 1-9. Detail
Dr Johanna Badcock, Professor Assen Jablensky, Dr Milan Dragovic 2002, 'High functioning people with schizophrenia: Neurocognitive and clinical profile', WA Foundation for Research into Schizophrenic Disorders.
2010 PhD. Dr Mazhari. Supervised by: Prof Jablensky, A/Prof Waters, Dr Price, Dr Dragovic